Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies ; volume:40 ; number:1 ; day:18 ; month:11 ; year:2021 ; pages:1-23 ; date:12.2021
Journal of experimental & clinical cancer research ; 40, Heft 1 (18.11.2021), 1-23, 12.2021
- Urheber
-
Xiao, Xinyi
Huang, Shengkang
Chen, Sifei
Wang, Yazhuo
Sun, Qihang
Xu, Xinjie
Li, Yuhua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-021-02148-6
- URN
-
urn:nbn:de:101:1-2022012818160881233310
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xiao, Xinyi
- Huang, Shengkang
- Chen, Sifei
- Wang, Yazhuo
- Sun, Qihang
- Xu, Xinjie
- Li, Yuhua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Steroid hormones and the T-cell cytokine profile
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy
CAR T-Cell therapy
Dynamics of the IL-2 cytokine network and T-cell proliferation
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
T-cell signaling of macrophage activation: cell contact dependent and cytokine signals
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
The Retinoic Acid Receptor-α mediates human T-cell activation and Th2 cytokine and chemokine production
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Steroid hormones and the T-cell cytokine profile
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy
CAR T-Cell therapy
Dynamics of the IL-2 cytokine network and T-cell proliferation
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
T-cell signaling of macrophage activation: cell contact dependent and cytokine signals
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
The Retinoic Acid Receptor-α mediates human T-cell activation and Th2 cytokine and chemokine production
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Steroid hormones and the T-cell cytokine profile
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy
CAR T-Cell therapy
Dynamics of the IL-2 cytokine network and T-cell proliferation
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
T-cell signaling of macrophage activation: cell contact dependent and cytokine signals
An in vitro model of the macrophage-endothelial interface to characterize CAR T-cell induced cytokine storm
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies